Hannover Rück SE Stock Timeline

2026-08-13

Latest price €250 anchors current valuation and investor reaction. Market participants use this quote for dividend yield, P/E calculations and assessment of 2026 earnings momentum. Short-term consolidation appears likely around this level following the 2026 rally, with range-bound trading more probable than immediate breakout [3][9].

2026 H1 (January–June)

Q1 group net income reached €711m with management confirming 2026 guidance intact. Q2 results sustained momentum, showing robust ROE and investment returns guidance around 3.5% [3][4][9].

Investor perception shifted decisively toward profitability and capital management. Steady reinsurance underwriting and resilient P&C combined ratios reduced catastrophe volatility concerns. Dividend sustainability and solvency strength became the dominant narrative [3][9].

Price rallied from 2025 levels into mid-2026 as results and guidance exceeded expectations, with periodic profit-taking interrupting the uptrend [3][8].

2025 (full year)

Full-year performance included a material dividend increase signalled in late 2025 disclosures. Management raised medium-term targets and committed to continued capital returns [5][9].

Investor perception shifted toward "compounder with shareholder returns" after repeated earnings beats and dividend increases. Confidence grew in underwriting discipline and investment income recovery [5][9].

Sustained uptrend throughout 2025 established the foundation for the 2026 rally. Higher highs and higher lows developed with increased volume on positive releases [5][13].

2024 (full year)

Net income surged with management raising outlook and increasing dividend. P&C profitability improved with favourable combined ratios and reserve releases [12][9].

Reassessment moved away from "cyclical reinsurance" toward higher-quality earnings narrative. Investors rewarded demonstrable underwriting improvements and resilience to mid-sized catastrophe activity [12][9].

Major rally phase developed through 2024, punctuated by short consolidations after quarterly releases as earnings surprises accumulated [12][8].

2023 (full year)

Group net income reached approximately €1.8bn despite several notable catastrophe losses: Italy storms, Türkiye–Syria earthquake, Hurricane Otis and Hawaii wildfires. Losses remained within budgeted parameters [12].

Market view shifted from post-pandemic normalization toward "resilient underwriting despite higher catastrophe frequency." The fact losses stayed within the large-loss budget supported confidence in management's risk budgeting [12][9].

Price recovered and rallied through 2023 after drawdown from 2022 catastrophe-affected periods, rotating from recovery into steady uptrend as earnings beat expectations [12][9].

2022 (full year)

Elevated major-loss expenditure and tougher environment for reinsurers followed the high-loss 2021–2022 period. Management increased the net major loss budget to approximately €1.3bn and guided for growth with modest investment returns. Combined ratios in P&C faced pressure in some quarters [7].

Investor concern about increased catastrophe frequency and earnings volatility intensified. Market characterized Hannover Re as cyclically exposed, with debate whether earnings would normalize or remain pressured [7].

Drawdown and volatile price action developed during 2022 as results and updated loss budgeting were digested. Range trading with downside bias followed, punctuated by volatility spikes around catastrophe events and quarterly reports [7][6].

2021 (January–December)

Significant mid-to-large loss activity in Q3 2021 increased net major loss expenditure materially to approximately €1.07bn by end-September. Group maintained profit guidance with outlook set for recovery and growth into 2022 with increased major loss budgeting [7].

Market skepticism grew amid rising natural catastrophe and pandemic-related claims. Hannover Re faced characterization as exposed to clustering of large losses, though management's guidance and capital position limited panic [7].

Price drew down following the Q3 2021 loss shock and earnings volatility. Extended consolidation and recovery phase developed into 2022 as investors awaited clearer loss trends and subsequent quarterly results [7].